Adverse Event Profile of Blinatumomab in Acute Lymphoblastic Leukemia
3 Pogledi
• 08/04/23
0
0
Ugraditi
administrator
Pretplatnici
In this segment, Raoul Tibes, MD, PhD, highlights common toxicities to be aware of in patients with acute lymphoblastic leukemia receiving blinatumomab therapy.
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari